Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development

Cellular Microbiology

Volumn 15, Issue 9, 2013, Pages 1508-1526

  Pei, Ying ^a   Miller, Jessica L ^a   Lindner, Scott E ^a   Vaughan, Ashley M ^a   Torii, Motomi ^b   Kappe, Stefan H I ^a,c  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; FALCIPAIN 2; UNCLASSIFIED DRUG; YOELIPAIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASEXUAL REPRODUCTION; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE TARGETING; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMODIUM YOELII; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; RODENTIA;

EID: 84881550162     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12124     Document Type: Article

References (51)

1. Alexander, D.L., Arastu-Kapur, S., Dubremetz, J.F., and Boothroyd, J.C. (2006) Plasmodium falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a component of the moving junction in Toxoplasma gondii. Eukaryotic Cell 5: 1169-1173.
2. Aly, A.S., and Matuschewski, K. (2005) A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J Exp Med 202: 225-230.
3. Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., etal. (2007) Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 25: 903-910.
4. Bergman, L.W., Kaiser, K., Fujioka, H., Coppens, I., Daly, T.M., Fox, S., etal. (2003) Myosin A tail domain interacting protein (MTIP) localizes to the inner membrane complex of Plasmodium sporozoites. J Cell Sci 116: 39-49.
5. Blackman, M.J. (2008) Malarial proteases and host cell egress: an 'emerging' cascade. Cell Microbiol 10: 1925-1934.
6. Coppi, A., Pinzon-Ortiz, C., Hutter, C., and Sinnis, P. (2005) The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J Exp Med 201: 27-33.
7. Dasaradhi, P.V., Mohmmed, A., Kumar, A., Hossain, M.J., Bhatnagar, R.K., Chauhan, V.S., and Malhotra, P. (2005) A role of falcipain-2, principal cysteine proteases of Plasmodium falciparum in merozoite egression. Biochem Biophys Res Commun 336: 1062-1068.
8. Desai, P.V., Patny, A., Sabnis, Y., Tekwani, B., Gut, J., Rosenthal, P., etal. (2004) Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. J Med Chem 47: 6609-6615.
9. Desai, P.V., Patny, A., Gut, J., Rosenthal, P.J., Tekwani, B., Srivastava, A., and Avery, M. (2006) Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory. J Med Chem 49: 1576-1584.
10. Dhawan, S., Dua, M., Chishti, A.H., and Hanspal, M. (2003) Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells. J Biol Chem 278: 30180-30186.
11. Dua, M., Raphael, P., Sijwali, P.S., Rosenthal, P.J., and Hanspal, M. (2001) Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1. Mol Biochem Parasitol 116: 95-99.
12. Eksi, S., Czesny, B., Greenbaum, D.C., Bogyo, M., and Williamson, K.C. (2004) Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth. Mol Microbiol 53: 243-250.
13. Farley, P.J., and Long, C.A. (1995) Plasmodium yoelii yoelii 17XL MSP-1: fine-specificity mapping of a discontinuous, disulfide-dependent epitope recognized by a protective monoclonal antibody using expression PCR (E-PCR). Exp Parasitol 80: 328-332.
14. Francis, S.E., Gluzman, I.Y., Oksman, A., Banerjee, D., and Goldberg, D.E. (1996) Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation. Mol Biochem Parasitol 83: 189-200.
15. Hansen, G., Heitmann, A., Witt, T., Li, H., Jiang, H., Shen, X., etal. (2011) Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium. Structure 19: 919-929.
16. Hanspal, M., Dua, M., Takakuwa, Y., Chishti, A.H., and Mizuno, A. (2002) Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 100: 1048-1054.
17. Hogg, T., Nagarajan, K., Herzberg, S., Chen, L., Shen, X., Jiang, H., etal. (2006) Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum. J Biol Chem 281: 25425-25437.
18. Jongco, A.M., Ting, L.M., Thathy, V., Mota, M.M., and Kim, K. (2006) Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii. Mol Biochem Parasitol 146: 242-250.
19. Kaushansky, A., Rezakhani, N., Mann, H., and Kappe, S.H. (2012) Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites. Mol Biochem Parasitol 183: 100-103.
20. Kumar, A., Kumar, K., Korde, R., Puri, S.K., Malhotra, P., and Singh Chauhan, V. (2007) Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential. Infect Immun 75: 2026-2034.
21. Labaied, M., Harupa, A., Dumpit, R.F., Coppens, I., Mikolajczak, S.A., and Kappe, S.H. (2007) Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun 75: 3758-3768.
22. Lee, B.J., Singh, A., Chiang, P., Kemp, S.J., Goldman, E.A., Weinhouse, M.I., etal. (2003) Antimalarial activities of novel synthetic cysteine protease inhibitors. Antimicrob Agents Chemother 47: 3810-3814.
23. Leiriao, P., Albuquerque, S.S., Corso, S., van Gemert, G.J., Sauerwein, R.W., Rodriguez, A., etal. (2005) HGF/MET signalling protects Plasmodium-infected host cells from apoptosis. Cell Microbiol 7: 603-609.
24. Lindner, S.E., Miller, J.L., and Kappe, S.H. (2012) Malaria parasite pre-erythrocytic infection: preparation meets opportunity. Cell Microbiol 14: 316-324.
25. Mack, S.R., Vanderberg, J.P., and Nawrot, R. (1978) Column separation of Plasmodium berghei sporozoites. J Parasitol 64: 166-168.
26. Menard, R., and Janse, C. (1997) Gene targeting in malaria parasites. Methods 13: 148-157.
27. Micale, N., Kozikowski, A.P., Ettari, R., Grasso, S., Zappala, M., Jeong, J.J., etal. (2006) Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents. J Med Chem 49: 3064-3067.
28. Mikolajczak, S.A., Aly, A.S., Dumpit, R.F., Vaughan, A.M., and Kappe, S.H. (2008) An efficient strategy for gene targeting and phenotypic assessment in the Plasmodium yoelii rodent malaria model. Mol Biochem Parasitol 158: 213-216.
29. Muralidharan, V., Oksman, A., Iwamoto, M., Wandless, T.J., and Goldberg, D.E. (2011) Asparagine repeat function in a Plasmodium falciparum protein assessed via a regulatable fluorescent affinity tag. Proc Natl Acad Sci USA 108: 4411-4416.
30. Na, B.K., Kim, T.S., Rosenthal, P.J., Lee, J.K., and Kong, Y. (2004) Evaluation of cysteine proteases of Plasmodium vivax as antimalarial drug targets: sequence analysis and sensitivity to cysteine protease inhibitors. Parasitol Res 94: 312-317.
31. Pandey, K.C., Singh, N., Arastu-Kapur, S., Bogyo, M., and Rosenthal, P.J. (2006) Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion. PLoS Pathog 2: e117.
32. Rennenberg, A., Lehmann, C., Heitmann, A., Witt, T., Hansen, G., Nagarajan, K., etal. (2010) Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes. PLoS Pathog 6: e1000825.
33. Rosenthal, P.J. (2004) Cysteine proteases of malaria parasites. Int J Parasitol 34: 1489-1499.
34. Salas, F., Fichmann, J., Lee, G.K., Scott, M.D., and Rosenthal, P.J. (1995) Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infect Immun 63: 2120-2125.
35. van de Sand, C., Horstmann, S., Schmidt, A., Sturm, A., Bolte, S., Krueger, A., etal. (2005) The liver stage of Plasmodium berghei inhibits host cell apoptosis. Mol Microbiol 58: 731-742.
36. Schmidt-Christensen, A., Sturm, A., Horstmann, S., and Heussler, V.T. (2008) Expression and processing of Plasmodium berghei SERA3 during liver stages. Cell Microbiol 10: 1723-1734.
37. Shenai, B.R., Sijwali, P.S., Singh, A., and Rosenthal, P.J. (2000) Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J Biol Chem 275: 29000-29010.
38. Shenai, B.R., Semenov, A.V., and Rosenthal, P.J. (2002) Stage-specific antimalarial activity of cysteine protease inhibitors. Biol Chem 383: 843-847.
39. Sijwali, P.S., and Rosenthal, P.J. (2004) Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc Natl Acad Sci USA 101: 4384-4389.
40. Sijwali, P.S., Shenai, B.R., Gut, J., Singh, A., and Rosenthal, P.J. (2001) Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem J 360: 481-489.
41. Sijwali, P.S., Kato, K., Seydel, K.B., Gut, J., Lehman, J., Klemba, M., etal. (2004) Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites. Proc Natl Acad Sci USA 101: 8721-8726.
42. Silvie, O., Greco, C., Franetich, J.F., Dubart-Kupperschmitt, A., Hannoun, L., van Gemert, G.J., etal. (2006) Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. Cell Microbiol 8: 1134-1146.
43. Singh, N., Sijwali, P.S., Pandey, K.C., and Rosenthal, P.J. (2006) Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2. Exp Parasitol 112: 187-192.
44. Sturm, A., Amino, R., van de Sand, C., Regen, T., Retzlaff, S., Rennenberg, A., etal. (2006) Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313: 1287-1290.
45. Subramanian, S., Hardt, M., Choe, Y., Niles, R.K., Johansen, E.B., Legac, J., etal. (2009) Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3. PLoS ONE 4: e5156.
46. Tarun, A.S., Dumpit, R.F., Camargo, N., Labaied, M., Liu, P., Takagi, A., etal. (2007) Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 196: 608-616.
47. Tarun, A.S., Peng, X., Dumpit, R.F., Ogata, Y., Silva-Rivera, H., Camargo, N., etal. (2008) A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 105: 305-310.
48. Turk, B., and Stoka, V. (2007) Protease signalling in cell death: caspases versus cysteine cathepsins. FEBS Lett 581: 2761-2767.
49. Vaughan, A.M., O'Neill, M.T., Tarun, A.S., Camargo, N., Phuong, T.M., Aly, A.S., etal. (2009) Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol 11: 506-520.
50. Vaughan, A.M., Mikolajczak, S.A., Wilson, E.M., Grompe, M., Kaushansky, A., Camargo, N., etal. (2012) Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest 122: 3618-3628.
51. Wickert, H., Wissing, F., Andrews, K.T., Stich, A., Krohne, G., and Lanzer, M. (2003) Evidence for trafficking of PfEMP1 to the surface of P. falciparum-infected erythrocytes via a complex membrane network. Eur J Cell Biol 82: 271-284.